[Synergism of cardiac glycosides and potassium-containing electrolyte mixtures].
D001224:Aspartic Acid; D002301:Cardiac Glycosides / Q000633:toxicity*; D004074:Digitoxin / Q000633:toxicity*; D004077:Digoxin / Q000633:toxicity*; D004357:Drug Synergism; D004573:Electrolytes / Q000633:toxicity*; D007552:Isotonic Solutions; D008274:Magnesium; D010042:Ouabain / Q000633:toxicity*; D010946:Plants, Medicinal / Q000633:toxicity*; D011188:Potassium / Q000633:toxicity*
D002301:Cardiac Glycosides; D004573:Electrolytes; D007552:Isotonic Solutions; D001224:Aspartic Acid; D010042:Ouabain; D004077:Digoxin; D004074:Digitoxin; D008274:Magnesium; D011188:Potassium
Uber das Zusammenwirken von Herzglykosiden und kaliumhaltigen Elektrolytgemischen.